Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression

Phyllis F. Cheung(German Cancer Research Center), Jens T. Siveke(German Cancer Research Center), Uwe Pelzer(Humboldt-Universität zu Berlin), Konstantinos Savvatakis(German Cancer Research Center), Marcus Bahra(Charité - Universitätsmedizin Berlin), Rui Fang(German Cancer Research Center), Karl S. Lang(Essen University Hospital), Sven‐Thorsten Liffers(German Cancer Research Center), Erik H.J.G. Aarntzen(Radboud University Nijmegen), Christian Neander(German Cancer Research Center), Igor Cima(Deutsches Konsortium für Translationale Krebsforschung), Lamin B. Cham(University of Duisburg-Essen), Kristina Althoff(German Cancer Research Center), Annette Paschen(University of Duisburg-Essen), Björn Scheffler(German Cancer Research Center), Elaine H. L. Siu(Chinese University of Hong Kong), Howard C. Crawford(Henry Ford Health System), Jana K. Striefler(Charité - Universitätsmedizin Berlin), Daniel R. Engel(Essen University Hospital), Camille Soun(Essen University Hospital), Anna Bazarna(German Cancer Research Center), Arianna Borgers(German Cancer Research Center), Anne Stoffel(German Cancer Research Center), P. M. Markus(Elisabeth-Krankenhaus Essen), Kirsten Krengel(German Cancer Research Center), ST Cheung(Immungenetics (Germany)), Chi Wai Yip(Chinese University of Hong Kong), Anthony W.H. Chan(Chinese University of Hong Kong), Helmut Oettle, Jiajin Yang(German Cancer Research Center), Xin Zhang(Wuhan University), Marianne Sinn(Charité - Universitätsmedizin Berlin), Smiths Lueong(German Cancer Research Center), Linda W.C. Ng(Chinese University of Hong Kong), E. Smeets(Radboud University Nijmegen)
Nature Communications
January 10, 2022
Cited by 94


Related Papers